Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent Receives 10th Anniversary CHIC IPO of the Year Award 2019-03-28 08:00
WuXi STA's New Drug Product Manufacturing Facility Passes First European MPA GMP Inspection 2019-03-27 14:00
Veeda Clinical Research Reaffirms Quality Credentials With Third Successful NPRA (Malaysian Regulatory Agency) Inspection 2019-03-27 07:00
Dr Thomas Ramdahl Joins Clarity Pharmaceuticals' Board 2019-03-26 08:30
Kazia to present on Cantrixil at American Association for Cancer Research (AACR) 2019 Annual Meeting 2019-03-25 13:25
WuXi AppTec Reports Strong 2018 Annual Results 2019-03-22 20:47
Inovio's Ebola Vaccine Delivered Intradermally Demonstrates 100% Immunogenicity in a Clinical Study Published in The Journal of Infectious Diseases 2019-03-21 21:11
Sasol Offers Support to Cyclone Idai Victims 2019-03-21 20:06
VisualDx's Web-based Clinical Decision Support System Acknowledged by Frost & Sullivan as Best in Class 2019-03-21 20:00
Adlai Nortye Receives NMPA Approval for Pelareorep (AN1004) in China to Initiate Phase III Clinical Trials 2019-03-21 18:21
Research from XJTLU advances RNA modification mapping 2019-03-21 16:42
Samsung BioLogics Wins 2019 CMO Leadership Awards in All Six Core Categories Three Years in a Row 2019-03-21 13:42
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody 2019-03-21 07:21
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody 2019-03-21 07:20
Merck Opens First M Lab™ Collaboration Center in Europe 2019-03-20 17:30
UK Schools Rank Last in Providing Oral Health Education, FDI Survey of 13 Countries Says 2019-03-20 08:00
I-Mab Biopharma and MorphoSys Announce Initiation of Pivotal Phase 2 Study of TJ202/MOR202 for Multiple Myeloma 2019-03-20 05:05
Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China 2019-03-19 18:30
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody in the U.S. 2019-03-19 08:09
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD 2019-03-18 23:58
1 308 309 310 311 312 440